HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Revenue

HLB Life Science had revenue of 15.20B KRW in the quarter ending March 31, 2026, with 61.02% growth. This brings the company's revenue in the last twelve months to 51.51B, up 46.49% year-over-year. In the year 2025, HLB Life Science had annual revenue of 45.75B with 39.61% growth.

• Revenue (ttm): 51.51B
• Revenue Growth: +46.49%
• P/S Ratio: 7.04
• Revenue / Employee: 336.68M
• Employees: 153
• Market Cap: 362.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	45.75B	12.98B	39.61%
Dec 31, 2024	32.77B	-65.22B	-66.56%
Dec 31, 2023	97.99B	-1.60B	-1.61%
Dec 31, 2022	99.59B	46.10B	86.17%
Dec 31, 2021	53.49B	-38.30B	-41.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error